learn.pharmalex.com

Backlink analytics and domain authority

Backlinks
All Dofollow Nofollow UGC DR ▾ Ref. domains ▾
+ Add filter
50 backlinks All New Lost
Referring page DR Ref. domains Linked domains Anchor and target URL
podcasts
https://www.pharmalex.com/thought-leadership/podcasts
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
combination-products-and-the-fda
https://www.pharmalex.com/thought-leadership/blogs/combination-products-and-the-fda
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
safety-reporting-requirements-for-marketing-in-the-eu
https://www.pharmalex.com/thought-leadership/podcasts/safety-reporting-requirements-for-marketing-in-the-eu
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
finding-the-best-approach-to-manage-sterility-assurance
https://www.pharmalex.com/thought-leadership/podcasts/finding-the-best-approach-to-manage-sterility-assurance
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
challenges-regulatory-landscape-for-atmps
https://www.pharmalex.com/thought-leadership/podcasts/challenges-regulatory-landscape-for-atmps
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
4
https://www.pharmalex.com/pharmalex-insights/webinars/department/regulatory-affairs-and-cmc/page/4
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
improving-efficiency-and-mitigating-risk-through-strategi...
https://www.pharmalex.com/thought-leadership/podcasts/improving-efficiency-and-mitigating-risk-through-strategic-product-development
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
whats-happening-with-ectd-4-0-new-and-future-developments
https://www.pharmalex.com/thought-leadership/podcasts/whats-happening-with-ectd-4-0-new-and-future-developments
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
medtech
https://www.pharmalex.com/pharmalex-industry-sectors/medtech
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
how-bayesian-thinking-addresses-complex-issues-with-clini...
https://www.pharmalex.com/thought-leadership/podcasts/how-bayesian-thinking-addresses-complex-issues-with-clinical-studies
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
notified-body-updates-for-mdd-mdrs-ivdd-and-ivdr
https://www.pharmalex.com/thought-leadership/blogs/notified-body-updates-for-mdd-mdrs-ivdd-and-ivdr
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
environment-and-climate-change-policy
https://www.pharmalex.com/thought-leadership/csr-document/environment-and-climate-change-policy
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
managing-the-medical-device-pre-submission-process-with-t...
https://www.pharmalex.com/thought-leadership/podcasts/managing-the-medical-device-pre-submission-process-with-the-fda
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
the-bio-pharmacy-market-authorisations-for-protein-based-...
https://www.pharmalex.com/thought-leadership/blogs/the-bio-pharmacy-market-authorisations-for-protein-based-medicines
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
ctr-in-focus-strategic-planning-to-transition-to-the-eu-c...
https://www.pharmalex.com/thought-leadership/blogs/ctr-in-focus-strategic-planning-to-transition-to-the-eu-clinical-trials-regulation
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
cmc-statistics
https://www.pharmalex.com/thought-leadership/white-papers/service/cmc-statistics
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
why-local-language-matters-with-medical-information-inqui...
https://www.pharmalex.com/thought-leadership/blogs/why-local-language-matters-with-medical-information-inquiries
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
raps-convergence-2025-transparency-trust-and-resilience-i...
https://www.pharmalex.com/thought-leadership/blogs/raps-convergence-2025-transparency-trust-and-resilience-in-regulatory-science
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
optimal-patient-access
https://www.pharmalex.com/pharmalex-insights/webinars/solution/optimal-patient-access
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
navigating-the-complex-field-of-radioligand-therapy-three...
https://www.pharmalex.com/thought-leadership/blogs/navigating-the-complex-field-of-radioligand-therapy-three-key-takeaways
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
optimal-patient-access
https://www.pharmalex.com/thought-leadership/podcasts/solution/optimal-patient-access
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
nls-days-2025
https://www.pharmalex.com/pharmalex-insights/events/nls-days-2025
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
cmc-statistics
https://www.pharmalex.com/thought-leadership/podcasts/service/cmc-statistics
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
pda-sterilisation-decontamination
https://www.pharmalex.com/pharmalex-insights/events/pda-sterilisation-decontamination
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
easing-the-pathway-for-combination-products-an-australian...
https://www.pharmalex.com/thought-leadership/journal-articles/easing-the-pathway-for-combination-products-an-australian-regulatory-perspective
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
sterility-testing-in-bioproduction-and-cell-and-gene-ther...
https://www.pharmalex.com/pharmalex-insights/events/sterility-testing-in-bioproduction-and-cell-and-gene-therapy-manufacturing
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
pharmalex-creates-specialized-biopharma-service-line
https://www.pharmalex.com/pharmalex-insights/company-news/industry-news-articles/pharmalex-creates-specialized-biopharma-service-line
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
solving-the-innovation-dilemma-with-integrated-product-de...
https://www.pharmalex.com/thought-leadership/podcasts/solving-the-innovation-dilemma-with-integrated-product-development
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
avoiding-pitfalls-with-your-product-development-strategy
https://www.pharmalex.com/thought-leadership/podcasts/avoiding-pitfalls-with-your-product-development-strategy
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
local-affiliate-services
https://www.pharmalex.com/pharmalex-solutions/local-affiliate-services
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
patient-safety-pharmacovigilance
https://www.pharmalex.com/thought-leadership/podcasts/department/patient-safety-pharmacovigilance
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
regulation-of-personalized-medical-devices-in-australia
https://www.pharmalex.com/thought-leadership/blogs/regulation-of-personalized-medical-devices-in-australia
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
good-morning-meeting-18-september-2025-copenhagen-denmark
https://www.pharmalex.com/thought-leadership/videos/good-morning-meeting-18-september-2025-copenhagen-denmark
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
regulatory-affairs-and-cmc
https://www.pharmalex.com/thought-leadership/journal-articles/department/regulatory-affairs-and-cmc
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
pipa-conference-explores-the-key-role-of-pv-across
https://www.pharmalex.com/thought-leadership/blogs/pipa-conference-explores-the-key-role-of-pv-across
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
netherlands
https://www.pharmalex.com/country/netherlands
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
a-new-age-of-regulatory-outsourcing
https://www.pharmalex.com/thought-leadership/blogs/a-new-age-of-regulatory-outsourcing
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
we-are-becoming-cencora-pharmalex
https://www.pharmalex.com/pharmalex-insights/company-news/industry-news-articles/we-are-becoming-cencora-pharmalex
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
2
https://www.pharmalex.com/thought-leadership/blogs/service/post-approval-maintenance/page/2
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
pharmalex.com
https://www.pharmalex.com/?Enquiry_Purpose&Job_Title&allFields&areas&campaign&company&content&country-list&data-protection&e-mail&errorMessage=Please correct the following errors:~~~ - This field is required~~~ - This field is required~~~ - This field is required~~~ - This field is required~~~ - This field is required~~~ - This field is required.~~~&errors=true&first-name&last-name&marketing-materials&medium&message&phone&referrer&source&state&term&url
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
research-and-development
https://www.pharmalex.com/thought-leadership/white-papers/department/research-and-development
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
toxicology-services-gmp
https://www.pharmalex.com/thought-leadership/blogs/toxicology-services-gmp
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
leveraging-overseas-evidence-for-market-entry-in-australi...
https://www.pharmalex.com/thought-leadership/blogs/leveraging-overseas-evidence-for-market-entry-in-australia-and-globally
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
videos
https://www.pharmalex.com/thought-leadership/videos
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
development-strategy
https://www.pharmalex.com/pharmalex-insights/webinars/service/development-strategy
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
quality-management-and-compliance
https://www.pharmalex.com/pharmalex-insights/webinars/department/quality-management-and-compliance
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
pharmalex-strengthens-global-reach-and-local-support-with...
https://www.pharmalex.com/pharmalex-insights/company-news/press-releases/pharmalex-strengthens-global-reach-and-local-support-with-offices-in-china
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
pharmacovigilance-audits
https://www.pharmalex.com/thought-leadership/white-papers/service/pharmacovigilance-audits
pharmalex.com
65 19 105
Training
https://learn.pharmalex.com/
DOFOLLOW
Next page →
Frequently Asked Questions
How many backlinks does learn.pharmalex.com have?
The backlinks page for learn.pharmalex.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on learn.pharmalex.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to learn.pharmalex.com dofollow or nofollow?
Backlinks to learn.pharmalex.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.